23 November 2017
News and Views
Links and Services
Genetic polymorphisms of tumor necrosis factor receptor superfamily affect responses to infliximab in Crohn's disease, shows May's issue of Alimentary Pharmacology & Therapeutics.
Tumor necrosis factor alpha is the key inflammatory cytokine involved in the pathogenesis of Croh
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors